Anaphylaxis and the inclusion of polysorbates in biotherapeutics
Both unwanted immunogenicity and anaphylaxis comprise major components of safety assessment, however, few if any attempts are made to differentiate drug-related from excipient-related anaphylaxis. Replacement of anaphylactogenic and immunogenic functional excipients with equally effective but safer...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
International Pharmaceutical Excipients Council
2017-12-01
|
| Series: | Journal of Excipients and Food Chemicals |
| Online Access: | https://jefc.scholasticahq.com/article/3115-anaphylaxis-and-the-inclusion-of-polysorbates-in-biotherapeutics |